Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
IMCAS World CongressIMCAS World Congress
Not Confirmed
Not Confirmed
29-31 January, 2026
IMCAS World CongressIMCAS World Congress
Not Confirmed
Not Confirmed
29-31 January, 2026
34th NZW-Hamburg34th NZW-Hamburg
Not Confirmed
Not Confirmed
30 January-01 February, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS




Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
IMCAS World CongressIMCAS World Congress
Industry Trade Show
Not Confirmed
29-31 January, 2026
IMCAS World CongressIMCAS World Congress
Industry Trade Show
Not Confirmed
29-31 January, 2026
34th NZW-Hamburg34th NZW-Hamburg
Industry Trade Show
Not Confirmed
30 January-01 February, 2026
Digital content

28 Jan 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/01/28/3227517/0/en/Biogen-s-Litifilimab-Receives-FDA-Breakthrough-Therapy-Designation-for-Cutaneous-Lupus-Erythematosus-a-Disease-With-No-Targeted-Treatment-Options.html

14 Jan 2026
// BIOSPACE
https://www.biospace.com/drug-development/jpm26-with-leqembi-launched-biogen-looks-to-expand-alzheimers-presence

12 Jan 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/01/12/3217160/0/en/Biogen-Receives-European-Commission-Approval-for-High-Dose-Regimen-of-SPINRAZA-nusinersen-for-Spinal-Muscular-Atrophy.html

05 Jan 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/01/06/3213279/0/en/Biologics-License-Application-for-Subcutaneous-Formulation-of-LEQEMBI-lecanemab-for-the-Treatment-of-Early-Alzheimer-s-Disease-Accepted-in-China.html

02 Jan 2026
// BUSINESSWIRE
https://www.businesswire.com/news/home/20260102921713/en/Samsung-Bioepis-Begins-Commercialization-of-BYOOVIZ-Biosimilar-to-Lucentis-Ranibizumab-in-Europe

09 Dec 2025
// PHARMIWEB
https://www.pharmiweb.com/press-release/2025-12-09/biogen-receives-health-canada-authorization-for-zurzuvae-zuranolone-the-first-and-only-treatment
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
Biogen is a supplier offers 3 products (APIs, Excipients or Intermediates).
Find a price of HUMANIZED MONOCLONAL ANTIBODY (IDEC-131) (CHO CELLS, IDEC) TO CD40L (CD 154) bulk offered by Biogen
Find a price of IDEC-114 (GALIXIMAB);CHEMERIC (MACAQUE/HUMAN) MONOCLONAL ANTIBODY TO CD80 (B7.1) bulk offered by Biogen
Find a price of MURINE MONOCLONAL ANTIBODY (2B8) TO CD20 bulk offered by Biogen